Back to Search
Start Over
Vancomycin-ResistantStaphylococcus aureus— Delaware, 2015
- Source :
- MMWR. Morbidity and Mortality Weekly Report. 64:1056
- Publication Year :
- 2015
- Publisher :
- Centers for Disease Control MMWR Office, 2015.
-
Abstract
- Vancomycin-resistant Staphylococcus aureus (VRSA) is a rare, multidrug-resistant bacterium of public health concern that emerged in the United States in 2002. VRSA (S. aureus with vancomycin minimum inhibitory concentration [MIC] ≥16 μg/mL) arises when vancomycin resistance genes (e.g., the vanA operon, which codes for enzymes that result in modification or elimination of the vancomycin binding site) from vancomycin-resistant enterococci (VRE) are transferred to S. aureus (1). To date, all VRSA strains have arisen from methicillin-resistant S. aureus (MRSA). The fourteenth VRSA isolate (VRSA 14) identified in the United States was reported to CDC in February 2015.
- Subjects :
- Vancomycin resistance
Health (social science)
biology
Vancomycin-resistant Staphylococcus aureus
Epidemiology
Operon
business.industry
Health, Toxicology and Mutagenesis
General Medicine
biochemical phenomena, metabolism, and nutrition
biology.organism_classification
medicine.disease
medicine.disease_cause
Microbiology
Minimum inhibitory concentration
Health Information Management
Staphylococcus aureus
medicine
Vancomycin
business
Bacteria
medicine.drug
Subjects
Details
- ISSN :
- 1545861X and 01492195
- Volume :
- 64
- Database :
- OpenAIRE
- Journal :
- MMWR. Morbidity and Mortality Weekly Report
- Accession number :
- edsair.doi...........529cc5ca593d21dd5ceef162b5b0678c